September, 2022.- The early detection of metastasis in patients with prostate cancer is the goal of ProstaMets, a prognostic test that analyzes the progression of this tumor through the detection of genetic markers. This technology –which has been awarded and highlighted in the R&D ecosystem– is a development of Environ, a biotechnological startup born in […]